ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

NIH Orders Duke Medical Center To Stop Enrollment In Human Research Studies

May 14, 1999

Wyden Asks Healy To Clarify CRADA Pricing Clause

January 3, 1992

Upper Endoscopy Most Effective When Performed in 3-Year Intervals

July 27, 2012

In Brief: Durant To Leave Alabama, Will Become President, Chief Executive Officer At Fox Chase Cancer Center

September 17, 1982

New Organ Systems Program Coordinating Center RFA Released

April 1, 1983

In Brief: Mauer Resigns St. Jude Director; Breslow Named DRCCA Board Chairman; Senate Considers Line Items

August 20, 1982